Full Breakdown
Trump Administration Agrees to Reevaluate NIH Grant Applications Amid Legal Challenges
12/31/2025, 4:27:57 AM
Overview of the Agreement
On December 29, 2025, the Trump administration reached an agreement to reevaluate thousands of National Institutes of Health (NIH) grant applications that had been stalled or denied due to policies perceived to be aligned with diversity, equity, and inclusion (DEI) initiatives. This decision follows a federal lawsuit led by Massachusetts Attorney General Andrea Joy Campbell and 15 other state attorneys general, who argued that the administration's actions disrupted vital public health research and harmed scientific careers.
Background & Context
The legal battle began when the Trump administration initiated a campaign to terminate grants it deemed inconsistent with its priorities, particularly those related to DEI. A federal judge, William G. Young, ruled in June 2025 that the NIH's termination of over 2,500 grants was likely unlawful, citing violations of the Administrative Procedure Act. The Supreme Court later upheld this ruling but directed that disputes over terminated grants be handled by the U.S. Court of Federal Claims.
Key Provisions of the Agreement
The agreement mandates that the NIH will review grant applications that were frozen, denied, or withdrawn based on the administration's directives rather than through the standard scientific review process. The NIH is required to make decisions on non-competitive renewal applications by December 29, 2025, and on other applications by mid-April or late July 2026, depending on their review status. However, the agreement does not guarantee funding for any specific application.
Impact on Researchers and Public Health
Researchers have expressed relief at the agreement, viewing it as a significant step toward restoring integrity to the grant review process. Nikki Maphis, a postdoctoral researcher at the University of New Mexico, stated, “This agreement allows my grant application, and many others, to move forward for review after an arbitrary and destructive freeze.” The agreement is expected to facilitate the continuation of critical research in areas such as Alzheimer’s disease, HIV prevention, and LGBTQ+ health.
Criticism & Opposition
Despite the positive reception from many researchers, concerns remain regarding the potential for continued political interference in the grant review process. Critics, including Jeremy Berg, a former NIH institute leader, have warned that while applications may be reviewed, the ultimate funding decisions could still be influenced by the administration's priorities. “The problem is the review is only part of the process,” Berg noted, highlighting the risk of projects being denied funding despite favorable evaluations.
Conflicting Reports & Gaps
While the agreement aims to clarify the status of stalled applications, there remains uncertainty about the NIH's future funding decisions. The Supreme Court's ruling has left unresolved issues regarding the jurisdiction over terminated grants, and the upcoming oral arguments in the First Circuit Court of Appeals on January 6, 2026, may further complicate the situation.
What's Next
The NIH is expected to begin reviewing the applications in accordance with the deadlines set forth in the agreement. However, the ongoing appeal regarding the legality of the NIH's previous directives will continue to shape the landscape of federal research funding, with implications for both current and future grant applications.
